In this Phase-2 , double-blind , multicenter study , 228 patients with moderate to severe knee osteoarthritis pain were randomized to a single intra-articular injection of FX006 ( containing 10 , 40 , or 60 mg of triamcinolone acetonide ) or 40 mg of immediate-release triamcinolone acetonide .